Details for New Drug Application (NDA): 018871
✉ Email this page to a colleague
NDA 018871 describes PROTOSTAT, which is a drug marketed by Ortho Mcneil Pharm and is included in one NDA. Additional details are available on the PROTOSTAT profile page.
The generic ingredient in PROTOSTAT is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
The generic ingredient in PROTOSTAT is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 018871
| Tradename: | PROTOSTAT |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | metronidazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018871
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Mar 2, 1983 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Mar 2, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
